A detailed history of Allspring Global Investments Holdings, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 38,799 shares of AMRX stock, worth $304,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,799
Previous 55,951 30.66%
Holding current value
$304,572
Previous $355,000 9.3%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$6.42 - $8.83 $110,115 - $151,452
-17,152 Reduced 30.66%
38,799 $322,000
Q2 2024

Jul 26, 2024

SELL
$5.36 - $7.11 $392,357 - $520,459
-73,201 Reduced 56.68%
55,951 $355,000
Q1 2024

Apr 18, 2024

SELL
$5.24 - $6.34 $45,126 - $54,600
-8,612 Reduced 6.25%
129,152 $782,000
Q4 2023

Jan 25, 2024

SELL
$3.36 - $6.21 $493,668 - $912,404
-146,925 Reduced 51.61%
137,764 $836,000
Q3 2023

Oct 27, 2023

BUY
$2.76 - $4.59 $785,741 - $1.31 Million
284,689 New
284,689 $1.2 Million
Q2 2023

Jul 18, 2023

SELL
$1.33 - $3.1 $1.71 Million - $3.98 Million
-1,283,443 Reduced 67.23%
625,479 $1.94 Million
Q1 2023

Apr 13, 2023

BUY
$1.27 - $2.7 $413,452 - $878,993
325,553 Added 20.56%
1,908,922 $2.65 Million
Q4 2022

Jan 23, 2023

BUY
$1.96 - $2.61 $1.52 Million - $2.02 Million
775,707 Added 96.04%
1,583,369 $0
Q3 2022

Oct 26, 2022

BUY
$2.02 - $3.62 $972,078 - $1.74 Million
481,227 Added 147.42%
807,662 $1.63 Million
Q2 2022

Jul 25, 2022

BUY
$3.01 - $4.46 $3,569 - $5,289
1,186 Added 0.36%
326,435 $1.04 Million
Q1 2022

May 02, 2022

SELL
$3.9 - $4.89 $477,558 - $598,785
-122,451 Reduced 27.35%
325,249 $1.36 Million
Q4 2021

Jan 28, 2022

BUY
$3.95 - $5.85 $1.77 Million - $2.62 Million
447,700 New
447,700 $2.14 Million

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.19B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.